ClinicalTrials.Veeva

Menu

Evaluation of an Anti-Shivering Protocol Cardiac Arrest

M

Methodist Health System

Status

Terminated

Conditions

Cardiac Arrest

Study type

Observational

Funder types

Other

Identifiers

NCT05264246
042.PHA.2021.D

Details and patient eligibility

About

This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019.

Full description

This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019. To allow for an adequate washout period, patients who were initiated on TTM before April 22, 2019 will be in the "before" group and patients initiated on TTM on or after June 1, 2019 will be in the "after" group. Patients will be identified based on electronic medical records search of order sets utilized in TTM and confirmed with manual chart review. Statistical analysis will be performed as detailed below.

Enrollment

165 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Diagnosis of cardiac arrest
  • Initiation of TTM via Arctic Sun® device

Exclusion criteria

  • Initiation of TTM > 12 hours after cardiac arrest
  • Receiving NMBs for an indication other than TTM
  • Early termination of TTM (less than 24 hours)

Trial contacts and locations

1

Loading...

Central trial contact

Zaid Haddadin, MS; Crystee Cooper, DHEd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems